Diacylglycerol kinase (DGK) metabolizes diacylglycerol (DG), a glycerolipid containing two acyl chains, to convert phosphatidic acid. DG is produced through phosphoinositide turnover within the membrane and is well known to act as a second messenger that modulates the activity of protein kinase C in the cellular signal transduction. Recent studies have revealed that DG also activates several proteins, including Ras guanine-nucleotide releasing protein and ion channels such as transient receptor potential proteins. Therefore, DGK is thought to participate in a number of signaling cascades by modulating levels of DG. Previous studies have disclosed that DGK is composed of a family of the isozymes, which differ in the structure, enzymological property, gene expression and localization, subcellular localization, and binding molecules. The present review focuses on the stories of phosphoinositide turnover and DG, including historical views, structural features, metabolism, and relevant cellular phenomena, together with the characteristics of DGK isozymes and the pathophysiological fi ndings on animal studies using knockout mice and models for human diseases. Now it is being revealed that the structural and functional diversity and heterogeneity of and around DGK support the proper arrangement of the complex signal transduction machinery.
Tohoku J. Exp. Med., 2008 , 214 (3), 199-212. © 2008 Diacylglycerol kinase (DGK) is an enzyme that metabolizes diacylglycerol (DG) to produce phosphatidic acid (PA). DG serves not only as a major intermediate product in the synthesis of several kinds of lipids but also as a bioactive molecule (English et al. 1996; Wakelam 1998) . Therefore, DGK is thought to participate in the signal transduction by modulating levels of DG in a variety of cellular responses to extracellular stimuli.
It is well known that DG acts as an allosteric activator for protein kinase C (PKC), and whose activity plays a central role in the control of proliferation and differentiation of many different the membrane, but serves as a functional molecule. "Phospholipid effect" was discovered a long time ago (Hokin and Hokin 1956) . A series of experiments revealed that in pigeon pancreas treated with acetylcholine or carbamyl choline, about 10-fold overall increase in the incorporation of 32 P-labeled phosphate into phospholipids was observed, which correlated with enhanced secretion of amylase. The increase in the label incorporation varied considerably among phospholipids, being 15-fold for PI, 3-fold for PA, and very lower for phosphatidylcholine (PC) and phosphatidylethanolamine (PE) (Hokin and Hokin 1953, 1954; Hokin 1985) . It was also shown that the PI lipids turn over rapidly in the brain, suggesting that they may play an important physiological role (Brockerhoff and Ballou 1962) . Those fi ndings stimulated the study on the implications of preferential metabolism of PI lipids.
It is well known that the receptor stimulation of the plasma membrane PI cycle leads to the production of two second messengers, inositol-1,4,5-trisphosphate (IP 3 ) and sn-1,2-DG. The idea initially came out from two observations: First, agonists that stimulated the hydrolysis of inositol phospholipids also induced intracellular mobilization of an established second messenger, Ca 2+ (Michell 1975) . Detailed investigation using different cell types revealed that the increase in IP 3 either preceded or coincided with the onset of the Ca 2+ signal (Berridge 1987) . Second, PLCdependent cleavage of phosphatidylinositol-4,5-bisphosphate (PIP 2 ) also produced the other product, namely DG. While IP 3 is free to diffuse throughout the cytosol, DG remains within the lipid bilayer. It was revealed that the activity of protein kinases from the brain was enhanced reversibly by lipid-soluble membrane components in the presence of Ca 2+ (Takai et al. 1979a,b; Kaibuchi et al. 1981) and that a neutral lipid, DG, drastically enhanced the reaction velocity while simultaneously reducing the Ca 2+ requirement of this kinase activity (Takai et al. 1979a,b; Kishimoto et al. 1980) . The enzyme containing such characteristics was designated PKC.
The idea that DG acts as an intracellular second messenger through activation of PKC was cell types (Nishizuka 1992; Newton 1995; Hurley et al. 1997; Ron and Kazanietz 1999) . In addition, recent studies have shown that DG also activates other proteins including the chimaerins (Caloca et al. 1999 ), Unc-13 (Nurrish et al. 1999) , protein kinase D (Baron and Malhotra 2002) , and some mammalian homologues of transient receptor potential proteins (Hofmann et al. 1999) . Furthermore, there have been reports that DG modulates the activity of several proteins in the Rho and Ras families, thus potentially affecting other cellular functions such as the cytoskeletal reorganization, cellular growth, and carcinogenesis (Takai et al. 2001; Topham 2006) . These studies suggest that DG is more widely implicated in cellular events than previously thought.
Together with DG, PA may also serve as a lipid second messenger and has been reported to interact with and regulate a growing list of signaling proteins, including phosphatidylinositol-4-phosphate (PIP) 5-kinase (Jenkins et al. 1994 ), phospholipase C (PLC)-γ 1 (Jones and Carpenter 1993) , PKC-ζ (Limatola et al. 1994) , and the mammalian target of rapamycin that governs the cell growth and proliferation by mediating the mitogen-and nutrient-dependent signal transduction in a variety of cells (Fang et al. 2001) . Collectively, DGK is thought to be one of the key enzymes closely involved in the lipid-mediated cellular signaling events, because it is directly involved in the control of the two lipid messenger molecules.
Recent studies have disclosed that DGK is composed of a family of isozymes and each has a unique character in terms of the expression and localization, the regulatory mechanism, binding molecules, and subcellular localization. This minireview focuses on the characteristics of this enzyme family and the second messenger DG.
Phosphoinositide turnover: a historical view
Phospholipids are a major component of the biosignaling system and contribute to the compartmentalization of cellular and intracellular environments. Of those, phosphoinositide (PI), a minor population (approximately 10%) of total membrane lipids, is not just a building block of additionally supported by the observation that tumor-promoting phorbol ester (tetradecanoylphorbol 13-acetate; synthetic analogue of DG) activated PKC in the presence of phospholipids. Phorbol ester induces a wide variety of cellular responses in vitro, including altered cell proliferation, differentiation, intracellular communication, and tumor promotion (Blumberg 1980; Nishizuka 1984) . Furthermore, it was suggested that DG produced in response to growth factors stimulated cell proliferation and that specifi c oncogenes may alter DG levels (Bell 1986 ). These fi ndings confi rmed the notion that altered levels of DG second messenger play an important role in the cellular transformation.
Characteristics of diacylglycerol
When we evaluate the role of DG in the signal transduction, we need to consider its biochemical and morphological characteristics, i.e., the kinetics of DG production, the molecular species of DG, and the subcellular sites for DG generation.
It was revealed that DG production occurs in a biphasic manner. In IIC9 fi broblasts a high concentration of α -thrombin (14 nM) induces a biphasic increase in DG mass. The early phase peaks at 15 sec and the later phase peaks at 5 min after stimulation (Wright et al. 1988) . DG levels remain elevated for at least 4 hrs as long as catalytically active α -thrombin is present. It is noteworthy that growth factors EGF and PDGF, in contrast to α -thrombin, induce a monophasic increase in DG levels at all mitogenic concentrations in IIC9 cells (Wright et al. 1988; Pessin et al. 1990 ), while PDGF-induced DG production is biphasic in NIH3T3 cells (Fukami and Takenawa 1989) . These different responses suggest the unique ability of agonists to stimulate cell typespecifi c DG-generating pathways.
In terms of the molecular structure, DG includes at least 50 structurally distinct molecular species, whose fatty-acyl groups can be polyunsaturated, di-unsaturated, mono-unsaturated or saturated (Hodgkin et al. 1998; Wakelam 1998) . In DG, a fatty acyl chain is attached to the sn-2-glycerol carbon via an ester linkage, while a fatty acyl chain at sn-1 may be linked via ester, ether, or alkenyl ether (Cook 1991) . The combination of two acyl chains at sn-1 and sn-2 positions generates diverse and distinct profi les of DG species. In this respect DG derived from PI is shown to be largely composed of polyunsaturated acyl chains, i.e., 1-stearoyl-2-arachidonoyl species, whereas PC-derived DG contains mono-unsaturated and saturated acyl chains (Holub and Kuksis 1978) . The extent to which particular DG species contribute to the signaling is uncertain, although there is some preference for polyunsaturated DG species with regard to PKC activation: Saturated DGs are generally poor activators, di-unsaturated DG more active, and polyunsaturated DGs, such as 1-stearoyl-2-arachidonoyl DG, most potent (Marignani et al. 1996; Schachter et al. 1996) .
In addition to molecular species, it is also important to mention the subcellular compartment in which DGs are located. Previously, DG formation by agonist-induced PI hydrolysis was assumed to occur at the plasma membrane. However, the quantifi cation of induced DG mass revealed that not all of the induced DG could be present at the plasma membrane. Using α -thrombin-stimulated fi broblasts, the total amount of induced DG was shown to represent nearly 1% of the total mass of cellular lipids (Wright et al. 1988; Pessin and Raben 1989; Pessin et al. 1990) . If the formation of all DG occurrs at the plasma membrane, it would result in destructive changes in the physical properties of the membrane (Siegel et al. 1989 ). Then, it was revealed that the early and small phase of production of DG occurs at the plasma membrane while the later and larger phase is produced in intracellular membranes, DGs of which are possibly derived from PI and PC, respectively (Martin et al. 1990) . In this regard it was reported that isolated rat liver nuclear envelop retains the ability to synthesize in vitro PA, PIP, and PIP 2 (Smith and Wells 1983) and that a robust, but transient, increase in nuclear DG is evident in quiescent IIC9 cells in response to α -thrombin (Leach et al. 1992; Jarpe et al. 1994) , showing that DG production in response to stimuli must occur not only at the plasma membrane but also in the nucleus.
Metabolism of diacylglycerol
In response to stimuli DG is produced transiently in cells and is metabolized at variable rates. For the removal of DG signal, there are four types of reactions identifi ed: phosphorylation by DGK to PA, breakdown by lipase to yield monoacylglycerols and free fatty acids, conversion to either PC or triglyceride (TG), and formation of bisphosphatidic acid. As far as mammalian system is concerned, it is diffi cult to delineate the contribution of DGK to the regulation of steady-state levels of DG because DG is a common precursor for glycerolipid synthesis and can be metabolized by several ways described above. It is thought that DGK acts at the early phase of PI signaling and that the contribution of DGK to metabolic processing of cellular DG is quantitatively minor when compared to other enzymes. However, recent perspective has gained an idea that the cellular DG pool is spatially and functionally segregated and that DGK is critically involved in attenuating DG produced in a signaling complex containing DGK or at certain restricted intracellular sites such as the plasma membrane, internal membranes and nucleus .
Discovery of diacylglycerol kinase activity
The DGK activity, conversion of DG to PA, was fi rst described in 1959 by Hokin and Hokin (1959) , who performed an experiment in which diglyceride prepared from cabbages was phosphorylated by ATP in the presence of brain microsomes and deoxycholate extracts of microsomes. The enzyme that catalyzes the formation of PA via this pathway was designated "diglyceride kinase." Since then the enzymatic activity has been shown to be widely distributed in animal tissues (Hokin and Hokin 1963; Sastry and Hokin 1966; Prottey and Hawthorne 1967; Lapetina and Hawthorne 1971; Billah et al. 1979; Farese et al. 1981) . In addition, the enzyme showed a wide variety of intracellular distribution in the brain, and the activity was found to be associated with membranes (Hokin and Hokin 1959; Call and Rubert 1973) and cytoskeleton (Daleo et al. 1974) in addition to the soluble fraction (Call and Rubert 1973) , suggesting the heterogeneity of DGK in animal organs, tissues, and cells. Because of the diffi culties associated with its assay and purifi cation (Walsh and Bell 1986a,b) , it was 1983 when the purifi cation of the enzyme was reported from pig brain for the fi rst time (Kanoh et al. 1983 ).
Molecular cloning and DGK isozymes
A soluble enzyme from pig brain of 80 kDa was purifi ed to homogeneity (Kanoh et al. 1983) , which was followed by subsequent purifi cation of the enzyme from porcine thymus (Sakane et al. 1989) . Then, the partial sequence information was used to design oligonucleotide probes to isolate cDNA clones. Molecular cloning of 80 kDa DGK was the fi rst to be reported among DGutilizing enzymes and revealed that the primary structure encodes 734 amino acids, which contain two cysteine-rich, zinc fi nger-like sequences and two Ca 2+ -binding EF-hand motifs, in addition to the ATP-binding site commonly included in protein kinases (Sakane et al. 1990 ). Interestingly, its mRNA was shown to be expressed most abundantly in the thymus, the organ used for the protein purifi cation.
Then, human (Schaap et al. 1990 ) and rat (Goto et al. 1992) homologues of this enzyme were reported. In situ hybridization histochemistry on rat brain revealed that mRNA for 80 kDa DGK is expressed in oligodendrocytes, but not in neurons (Goto et al. 1992 ). It has been well known that neuron plays a leading role in the signal propagation in the brain while glial cell a supportive one. The unexpected localization of 80 kDa DGK in oligodendrocytes in the brain, together with the previous report suggesting the existence of other immunologically distinct DGKs (Yamada and Kanoh 1988) , motivated researchers to isolate other forms of DGK. Intensive screening in the brain by the present author resulted in the isolation of another DGK of 90 kDa (Goto and Kondo 1993) . Interestingly, this novel DGK was shown to be expressed in neurons of restricted region of the brain. The restricted expression pattern meant that the "neuronal type" is not a single entity but is composed of multiple sub-types, which might localize differentially in various neurons. Comparison between the amino acid sequences of two distinct DGK isozymes made it possible to predict conserved sequences of a "putative" enzyme family and to design degenerate primers for "PCR cloning", which contributed to a series of molecular cloning of the DGK family. Databases from EST program and genome projects of several species further accelerated identifi cation of more DGKs by "computer cloning." In 1996, as many as six isozymes of DGK were reported in several species including human, rat, and hamster.
As summarized in Figure 1 , ten mammalian DGK isozymes are already identifi ed at present (Sakane and Kanoh 1997; van Blitterswijk and Houssa 2000; Martelli et al. 2002; Goto and Kondo 2004; Luo et al. 2004; Goto et al. 2006; Topham 2006; Evangelisti et al. 2007a; Sakane et al. 2007 ), which are classifi ed into fi ve groups based on the structural motifs. Class I comprises the α (Sakane et al. 1990; Schaap et al. 1990 ), β (Goto and Kondo 1993) , and γ (Goto et al. 1994; Kai et al. 1994) ; class II the δ (Sakane et al. 1996) , η (Klauck et al. 1996) , and κ (Imai et al. 2005) ; class III the ε ; class IV the ζ Goto and Kondo 1996) and ι (Ding et al. 1998) ; class V the θ (Houssa et al. 1997) . Furthermore, alternative splice variants have been reported in several of such isozymes as DGKβ (Caricasole et al. 2002) , -γ (Kai et al. 1994) , -δ , -η (Murakami et al. 2003) , -ι (Ito et al. 2004) , and -ζ (Ding et al. 1997) .
Several domains and motifs are contained in mammalian DGKs. Major ones include a conserved catalytic domain in the C-terminal region and two cysteine-rich, Zn 2+ -fi nger motifs (three for DGKθ ), similar to the C1A and C1B motifs of PKC but lacking certain consensus residues present in phorbol ester-binding proteins. Class II isozymes have bipartite catalytic domains. The cysteine-rich, Zn 2+ -fi nger motifs are presumed to bind DG and present it to the catalytic domain.
Additional domains or motifs conceivably confer isozyme-specifi c functions in the biosignaling system, the sensitivity to different regulatory mechanisms, and the subcellular localization. -fi nger motifs are included in all of the isozymes. Class II isozymes have bipartite catalytic domain. EF, Ca 2+ -binding EF hand; Zn-fi nger, cysteine-rich, Zn 2+ -fi nger motif; PH, pleckstrin-homology domain; SAM, sterile α motif; EPAP, 33 tandem repeats of Glu-Pro-Ala-Pro; PDZ, PSD-95/Discs large/zona occludens-1 domain; MARCKS, sequence homologous to myristoylated alanine-rich C-kinase substrate phosphorylation site domain; NLS, nuclear localization signal; Ankyrin repeats; PR, prolineand glycine-rich domain; RA, Ras-association domain.
Indeed, these are likely to play a role in lipid-protein and protein-protein interactions in various signaling pathways. Class I DGKs contain Ca 2+ -binding EF domains in their N-terminal half, so that they are activated in the presence of Ca 2+ . Class II isozymes have a pleckstrin homology (PH)-like domain at their N-terminal portion, which might be involved in interactions with lipids. DGKδ and -η contain at the C-terminus sterile α motif (SAM) domain (Sakane et al. 1996; Murakami et al. 2003) , which is shown to localize DGKδ to the endoplasmic reticulum (ER) where it regulates ER-to-Golgi traffi c (Nagaya et al. 2002) . On the other hand, DGKκ contains a unique motif, EPAP repeats comprised of 33 tandem repeats of Glu-Pro-Ala-Pro at the N-terminus (Imai et al. 2005) . DGKε that belongs to Class III is the only isozyme which has no domains with obvious regulatory functions but shows a substrate preference toward arachidonoyl-DG at the sn-2 position . Class IV isozymes contain four C-terminal ankyrin repeats, a PDZ (postsynaptic density protein-95/Discs large/ zona occludens-1) domain, and a nuclear localization signal (NLS) which overlaps with a region homologous to the phosphorylation site of the PKC substrate "myristoylated alanine-rich C-kinase substrate (MARCKS)" Goto and Kondo 1996) . Class V DGKθ has a region with weak homology to PH domain, which overlaps with a Ras-associating domain (Houssa et al. 1997 ).
Substrate specifi city of diacylglycerol kinase
Before the advent of molecular technology, studies using partially purifi ed proteins reported the DGK activity in the cytosol or microsomes of the brain and liver and found little or no selectivity among different DG species. However, it was found in Swiss 3T3 cells that the membranebound and cytosolic DGKs utilized DG in octylglucoside mixed micelles and were activated by PS although they differed in the substrate selectivity (MacDonald et al. 1988 ). The membranebound DGK selectively phosphorylated DG with arachidonic acid at the sn-2 position. It was also revealed that this membrane-bound DGK was rapidly and selectively inactivated by preincubation with its preferred substrate, suggesting the thermal lability of this enzyme. More importantly, the substrate preference of this enzyme toward the arachidonoyl-DG was greatly dependent on the assay system (MacDonald et al. 1988; Lemaitre et al. 1990; Walsh et al. 1994 ).
Comparison of different assay systems using different detergents, i.e., the octylglucoside mixed micelle assay, deoxycholate assay, and Triton X-100 assay, revealed that the substrate selectivity of arachidonoyl DGK was most evident in the octylglucoside assay. Furthermore, the enzyme exhibited no substrate preference in the deoxycholate assay. Therefore, the inability to detect the substrate specifi city in previous studies may be explained by the characteristics of the arachidonoyl DGK, i.e. the thermal lability and assay system employed. Arachidonoyl DGK had been purifi ed to apparent homogeneity from bovine testis and estimated the molecular mass as 58,000 (Walsh et al. 1994) , although isolation of cDNA clone for that isozyme (DGKε ) was done by a PCR cloning with degenerate primers for the conserved amino acid sequences .
What is the functional implications of the substrate specifi city toward arachidonoyl-DG? One possibility is that arachidonoyl-specifi c DGKε may attenuate specifi cally the signal of arachidonoyl-DG derived mostly from the breakdown of PI, although the other isozymes are also capable of catalyzing arachidonoyl-DG nonspecifi cally (Holub and Kuksis 1978) . Alternatively, if DGKε works specifi cally on the arachidonatecontaining species of DG, multiple cycles of this pathway would progressively enrich PI with arachidonate (Prescott and Majerus 1981; Glomset 1996) . Therefore, DGKε may be closely involved in the cellular PI cycle (see Section "Animal models and knockout mice").
Subcellular localization of diacylglycerol kinase
One of the prominent features of most, if not all, of the isozymes is an abundant expression in the brain. Interestingly, they are shown to be expressed differentially in various regions of the brain (Goto and Kondo 1999) . Comparative analysis suggests that a given type of neurons express a specifi c set of the isozymes and that more than one isozyme is co-expressed in a single neuron in various brain regions. But, why are so many isozymes expressed in a single neuron?
Biochemical analysis of the subcellular distribution of DGK isozymes showed that some are cytosolic, some are associated with membranes, and some are localized to the nucleus. Distinct properties of the subcellular localization have been directly compared by cDNA-transfection experiments under the same conditions (Fig. 2) . The results reveal that DGKβ colocalizes with actin fi laments, DGKγ with the Golgi complex, DGKε with the ER, and DGKζ is localized to the nucleus while DGKα is diffusely distributed in the cytoplasm and the nucleus (Kobayashi et al. 2007 ). As for DGKζ , it is clearly shown by immunohistochemistry using specifi c antibody that this isozyme is localized to the nucleus of several types of fully differentiated cells, including neurons (Hozumi et al. 2003; Sasaki et al. 2006) and alveolar epithelial cells and macrophages in the lung (Katagiri et al. 2005) . However, it remains unexplored whether the other isozymes show the same pattern of subcellular localization in native cells in situ as in transfected cultured cells, because each cell type has its unique regulatory mechanism for the subcellular elements, such as organelles and cytoskeletons, in order to accommodate itself to the environment.
It is worthy to mention a translocation between the cytosol and the particulate structures and/or between organelles. In the case of DGK, we should consider the fact that the substrate DG is membrane-bound and therefore DGK must bind to the membrane, at least transiently, to reach the substrate. In this regard, DGK was shown to translocate from the cytosol to the membrane in homogenates of rat brain and liver, dependent on the content of membrane-bound DG, although which isozyme is responsible for the translocation remained undetermined (Besterman et al. 1986 ). This suggests that DGK may be partially, if not completely, activated by its own substrate DG and that DGK itself might be one of the targets of a second messenger DG. In this regard, it is reported that DGK may contain DG-binding sites in addition to the enzyme's substrate binding site (Thomas and Glomset 1999) . All of the mammalian DGKs share cysteine-rich, zinc-fi nger motifs similar to the C1A and C1B motifs of PKC but lack certain consensus residues present in phorbol ester-binding proteins (van Blitterswijk and Houssa 2000; Topham 2006; Sakane et al. 2007 ). It might be plausible that zinc-fi nger motifs may promote the enzyme's binding to the membrane. It is also conceivable that the presence of DG in the membrane may alter the physical properties of the membranous microenvironment.
With regard to individual isozyme species involved in the translocation, DGKα has been shown to translocate from the cytoplasm to the plasma membrane upon T cell activation, and resulting phosphorylation of DG causes a rapid release of the enzyme back to the cytoplasm (Sanjuan et al. 2001) . This represents the reversible translocation. There has been another report of the translocation under pathological conditions. In transient ischemic brain model, DGKζ , an iso- DGK isozymes show different sublcellular localization in cDNA-transfected COS cells. DGKβ colocalizes with actin fi laments (linear lines), DGKγ with the Golgi complex, DGKε with the ER, and DGKζ is localized to the nucleus while DGKα is diffusely distributed in the cytoplasm and the nucleus. The data is based on the previous report (Kobayashi et al. 2007) .
zyme that localizes to the nucleus in neurons (Hozumi et al. 2003) , is translocated from the nucleus to the perikaryal cytoplasm in pyramidal neurons of the hippocampal CA1 at the very early phase of ischemic insult and never comes back to the nucleus during the time course of reperfusion (Ali et al. 2004) . It is known that delayed neuronal death occurs in hippocampal CA1 neurons 48 -72 hrs after reperfusion in this transient forebrain ischemia (Kirino 1982) . Rapid and irreversible disappearance of DGKζ from the nucleus of ischemic neurons might be involved in this mode of neuronal death. On the other hand, MARCKS of DGKζ can be phosphorylated by conventional PKCα and -γ isoforms (Topham et al. 1998) , and it is suggested that the phosphorylation facilitates DGKζ export from the nucleus in transfected cells, although this event has not been confi rmed in native cells. Collectively, it is suggested that a variety of factors may infl uence the subcellular localization of DGKs under pathophysiological conditions.
Phosphoinositide turnover and diacylglycerol in the nucleus
Nuclear PI turnover was fi rst provided by the observations that isolated rat liver nuclear envelops retain the ability to synthesize in vitro PA, PIP, and PIP 2 (Smith and Wells 1983) . In addition, envelope-deprived nuclei from murine erythroleukemia cells could synthesize in vitro PIP as well as PIP 2 , showing that inositol lipid metabolism also occurs in the internal domain of the nucleus (Cocco et al. 1987 ). The nuclear PIP 2 synthesis was more pronounced if the cells were differentiated along the erythroid pathway by dimethyl sulfoxide (DMSO). Interestingly, in the insulin-like growth factor-I (IGF-I)-stimulated Swiss 3T3 cells, a rapid decrease in the mass of polyphosphoinositol lipids occurs within the nuclei, with a concomitant increase in nuclear DG and translocation of PKC to the nuclear region, while bombesin-stimulation causes similar changes of inositol lipid at the plasma membrane, but has no effects on nuclear inositide levels and causes a translocation of PKC to post-nuclear membrane (Divecha et al. 1991) . This suggests that nuclear PI signaling system is regulated differentially from the plasma membrane system.
In the nucleus there seem to exist two distinct subnuclear pools of DG (D'Santos et al. 1999) . One is highly polyunsaturated and is likely derived from the hydrolysis of PI through the action of PI-specifi c PLC. The other pool is highly disaturated and mono-unsaturated species (more than 90% of the total nuclear DG) and is derived from various pathways, one of which may be through the hydrolysis of PC. Interestingly, two separate pools of DG are independently regulated in the nucleus: In MEL cells the differentiation along the erythroid pathway by DMSO leads to a decrease in the levels of disaturated and monounsaturated DG when assayed using intact nuclei. On the other hand, during progression through the cell cycle, no changes are seen in the levels of mono-unsaturated and disaturated DG. In contrast, however, there is 3-fold increase in the nuclear PA labeling 2 hrs after release of cells from a nocodazole-induced block at G2/M phase. The increase of PA was completely inhibited by PI-PLC inhibitors, and more than 70% of the PA was highly polyunsaturated species. Therefore it is suggested that the nuclear DG pools are not always accessible to the nuclear DGK and DGs with different acyl chains may be compartmentalized in the nucleus.
How is the DG signal turned off in the nucleus? When quiescent Swiss 3T3 cells are stimulated with a mitogenic concentration of IGF-I, there is a rapid and sustained increase in the nuclear DG levels up to 60 min (Martelli et al. 2000) . After the beginning of the treatment, nuclear DGK activity is unchanged up to 30 min of IGF-I stimulation, and then it starts to rise, reaching the maximum at 90 min. These results show that an inverse relationship exists in the nucleus of IGF-I-stimulated Swiss 3T3 cells between the levels of DG and DGK activity. Treatment of cells with DGK inhibitors blocks the IGF-I-dependent rise in nuclear DGK activity and maintains elevated intranuclear levels of DG. The results suggest that DGK plays a key role in regulating stimulated cell growth as DGK inhibitors potentiate the mitogenic effect of IGF-I.
In relation to the cell cycle, a previous study reports that nuclear DG levels fl uctuate during the cell cycle and that changes in nuclear DG levels correlate with the cell cycle progression through the G2/M phase (Sun et al. 1997) . In addition, a nuclear PI-PLC activity is activated during the G2 phase and PI-PLC inhibitors lead to a decrease in nuclear PI-PLC activity and a cell cycle blockade at the G2 phase (Sun et al. 1997) . In this regard, DGKζ may bind to the retinoblastoma protein (pRB), a tumor suppressor and key regulator of the cell cycle, whose activity depends on the phosphorylation status of pRB (Los et al. 2006) . Furthermore, overexpression of a wild-type DGK ζ blocks the cell cycle at the G1 phase (Topham et al. 1998 ) and decreases levels of pRB phosphorylation on Ser-807/811 (Evangelisti et al. 2007b ). More importantly, it is shown that endogenous DGKζ acts as a repressor of DNA replication, as its down-regulation resulted in a higher percentage of cells being at the S and G2/M phases of the cell cycle (Evangelisti et al. 2007b ). These results suggest that nuclear DGKζ is a key determinant of cell cycle progression and differentiation of C2C12 cells.
Animal models and knockout mice
There have been several studies on pathophysiological implications of the DGK family using animal models for several diseases and knockout mice with main attention on the brain, heart, and T-lymphocyte.
Insults by ischemia and infarction on the brain represent the major causes of human death and has been a subject for intensive investigation for a long time. In addition to the transient forebrain ischemic model (see Section "Subcellular localization of diacylglycerol kinase"), the infarction model of focal middle cerebral artery occlusion (MCAO) has been used to investigate how DGK is involved in these devastating conditions (Nakano et al. 2006 ). According to their fi nding, the hypoperfusion of blood fl ow greatly attenuates the expression levels of DGKζ in the nucleus of cortical neurons in an affl icted area soon after 90 min occlusion. Taken the results from transient cerebral ischemia together, the rapid disappearance of DGKζ in neuronal nucleus at the early phase of ischemia suggests that DGKζ may play an important role in intranuclear events induced in ischemic neurons at the early stage.
In the late infl ammatory process of infarction, DGKζ appears in non-neuronal cells, such as activated phagocytes/macrophages and endothelial cells (Nakano et al. 2006 ). Ischemic necrosis is followed by activation of the glial and infl ammatory cells, and this response may play a critical role in the development of brain damages. This suggests a possible involvement of DGKζ in the phagocytic process and vascular reconstruction. Together, the MCAO model study reveals that DGKζ is involved in both the early ischemic process and the late infl ammatory process of the cerebral infarction.
Cardiac hypertrophy is an initially adaptive response in several forms of cardiac diseases, whereas sustained hypertrophy is a powerful independent risk factor for cardiac morbidity and mortality (Levy et al. 1990 ). Previous studies of human heart failure and animal models of heart failure including genetically engineered mice have clearly shown that the activation of PKC plays a critical role under these conditions (Bowling et al. 1999; Takeishi et al. 1998 Takeishi et al. , 1999 Takeishi et al. , 2000 , suggesting that DGK may be closely involved in the cardiac dysfunction. In this regard, DGKζ has been shown to block endothelin-1-induced activation of the PKCε -ERK-AP1 signaling pathway, atrial natriuretic factor gene induction, and resultant cardiomyocyte hypertrophy (Takahashi et al. 2005) . Furthermore, a recent study should be noted on the evaluation of possible roles of DGKζ in the cardiac function using an animal model of transgenic mice with cardiac-specifi c overexpression of DGKζ (DGKζ -TG) (Arimoto et al. 2006) . While in wild type mice, a continuous administration of subpressor doses of angiotensin II and phenylephrine causes PKC translocation, gene induction of atrial natriuretic factor, and subsequent cardiac hypertrophy, in DGKζ -TG mice neither translocation of PKC nor up-regulation of atrial natriuretic factor gene expression is observed after infusion of angiotension II and phenylephrine. A similar effect of DGKζ has been reported in the cardiac hypertrophy model created by transverse constriction of thoracic aorta. Increases in the heart weight and interventricular thickness, dilatation of the left ventricular cavity, and decreases in left ventricular systolic function are attenuated in DGKζ -TG mice (Harada et al. 2007 ). These studies clearly show that DGKζ negatively regulates the hypertrophic signaling cascade, suppresses the cardiac hypertrophy and fi brosis, and prevents impaired left ventricular systolic function caused by pressure overload at the animal level.
Furthermore, DGKζ seems to exert beneficial effects on infarcted heart. In DGKζ -TG mice, DGKζ suppresses left ventricular structural remodeling and fi brosis, which improves the survival rate after myocardial infarction ). It should be noted that DGKζ -TG mice are indistinguishable from WT mice in physiological or histological analyses (Arimoto et al. 2006) , showing that overexpression of DGKζ produces no harmful effects under normal conditions. Collectively, these features of DGKζ suggest that this isozyme may be a potential novel therapeutic target to prevent unwanted cardiac conditions produced by pressure overload and myocardial infarction .
Functional analyses of DGK isozymes have been performed on knockout mice of DGKs, including DGKα (Olenchock et al. 2006) , DGKζ (Zhong et al. 2003) , DGKδ (Crotty et al. 2006) , DGKε (Rodriguez de Turco et al. 2001) , and DGKι (Regier et al. 2005) . DGKα and DGKζ are implicated in T cell receptor (TCR) signaling, especially T cell anergy. DGKα -defi cient T cells have a more DG-dependent TCR signaling and in vivo anergy induction is impaired in DGKα -deficient mice (Olenchock et al. 2006) . It should be noted that DGKζ -null T cells are also hyperresponsive to TCR stimulation, as manifested by enhanced activation of the Ras-ERK cascade, expression of activation markers, proliferation ex vivo and in vivo, and antiviral immune responses (Zhong et al. 2003) . These studies suggest that DGKα and DGKζ serve as physiological negative regulators of TCR signaling, although a functional difference between these two DGK isozymes remains undetermined.
DGKδ -KO mice have eyelids open at birth and die soon because of the respiratory diffi culty (Crotty et al. 2006) . The study on isolated cells reveals that DGKδ -defi ciency reduces EGF receptor (EGFR) protein expression and activity. This may be due to increased threonine phosphorylation of EGFR by PKC, which may contribute to the phenotypes, such as the open eyelids at birth and respiratory distress, of the mutant mice. DGK ε -defi cient mice are more resistant to the electroconvulsive shock (ECS) with shorter tonic seizures and faster recovery than WT mice (Rodriguez de Turco et al. 2001) . Interestingly, this behavioral response is paralleled by lower degradation of brain PIP 2 after ECS. Considering the substrate preference of DGKε toward the arachidonoyl-containing DG, it is presumed that DGKε is intimately involved in resynthesis and/or turnover of PIP 2 after the stimulation. It is known that DGKι binds and regulates RasGRP3 and predominantly reduces Rap1 activation (Regier et al. 2005) . This, together with the fi nding that DGKι -KO mice develop fewer tumors in response to a phorbol ester or after wounding (Regier et al. 2005) , suggests that deleting DGKι in mice may reduce the tumor formation in Ras-dependent manner.
Concluding remarks
It was long ago, about a half century ago, when the enzymatic activity of DGK was fi rst reported in the brain microsomes. Tremendous efforts on the enzymology in combination with the recent development of powerful molecular biology have greatly contributed to the unveiling of the characteristic features of the DGK family in terms of the enzymological property, gene expression and localization, subcellular localization, regulatory mechanism and disclosure of binding partners in tissues and cells. Now, there has come a time to integrate the fragmental informations into a pathophysiological story at the organism level. In this regard, knockout mice and databases on human diseases would be precious tools to make the story. Future scientists are always on the shoulders of scientists of the past and the present.
